Unaudited Pro Forma Combined Statement of Operations of the Borrower for the fiscal year ended December 31, 1997.

Unaudited Pro Forma Combined Statement of Operations. For the Fiscal Years Ended September 30, 2006 and December 31, 2006 (in thousands) Arrowhead Research October 1, 2005 - September 30, 2006 Carbon Nanotechnologies, Inc. January 1, 2006 - December 31, 2006 Proforma Adjustments Proforma Combined REVENUE $ 595 $ 3,109 $ — $ 3,704 COST OF GOODS SOLD — 2,024 — 2,024 GROSS PROFIT 595 1,085 — 1,680 OPERATING EXPENSES Salaries 6,471 2,181 — 8,652 Consulting 750 — — 750 General and administrative expenses 5,034 1,427 — 6,461 Research and development 8,582 369 5,760 (3) 14,711 Depreciation and amortization 242 317 (233 ) (4) 326 Goodwill impairment & other charges 999 — — 999 TOTAL OPERATING EXPENSES 22,078 4,294 5,527 31,899 OPERATING LOSS (21,483 ) (3,209 ) (5,527 ) (30,219 ) OTHER INCOME (EXPENSES) Gain on sale of assets — 20 — 20 Realized and unrealized gain (loss) in marketable securities 316 — — 316 Interest income 853 12 — 865 Interest expense — (241 ) 241 (4) 0 Other income (expense) — (15 ) — (15 ) TOTAL OTHER INCOME (EXPENSES) 1,169 (224 ) 241 1,186 LOSS BEFORE MINORITY INTERESTS (20,314 ) (3,433 ) (5,286 ) (29,033 ) Minority interests 1,317 — — 1,317 LOSS FROM CONTINUING OPERATIONS (18,997 ) (3,433 ) (5,286 ) (27,716 ) Provision for income taxes — — — — NET LOSS $ (18,997 ) $ (3,433 ) $ (5,286 ) $ (27,716 ) Loss from continuing operations per share $ (0.595 ) $ (0.280 ) $ (0.839 ) Net loss per share, basic and diluted $ (0.595 ) $ (0.280 ) $ (0.839 ) Weighted average shares outstanding 31,953,806 12,256,253 33,033,806 See Notes to Unaudited Pro Forma Combined Financial Statements Unaudited Pro Forma Combined Statement of Operations For the First Quarters Ended December 31, 2006 and March 31, 2007 (in thousands) Arrowhead Research First Quarter October 1, 2006 - December 31, 2006 Carbon Nanotechnologies, Inc. First Quarter January 1, 2007 - March 31, 2007 Proforma Adjustments Proforma Combined REVENUE $ 11 $ 877 $ — $ 888 COST OF GOODS SOLD — 620 — 620 GROSS PROFIT 11 257 — 268 OPERATING EXPENSES Salaries 1,727 510 — 2,237 Consulting 231 — — 231 General and administrative expenses 1,177 495 — 1,672 Research and development 1,246 52 — 1,298 Depreciation and amortization 104 72 (58 ) (4) 118 Goodwill impairment & other charges — — — — TOTAL OPERATING EXPENSES 4,485 1,129 (58 ) 5,556 OPERATING LOSS (4,474 ) (872 ) 58 (5,288 ) OTHER INCOME (EXPENSES) Gain on sale of assets — — — 0 Interest income 313 4 — 317 Interest expense — (77 ) 77 (4) 0 Other income (expense) — (6 ) — (6 ) TOTAL OTHER INCOME (EXPENSES) 31...

Unaudited Pro Forma Combined Statement of Operations. (In thousands, except share and per share information) For the six months ended June 30, 2014 JetPay ACI Combined Before Acquisition Adjustments Pro Forma Acquisition Adjustments Note # Pro Forma Combined Processing revenues $ 15,895 $ 3,205 $ 19,100 - $ 19,100 Cost of processing revenues 9,421 1,830 11,251 - 11,251 Gross profit 6,474 1,375 7,849 - 7,849 Selling, general and administrative expenses 6,183 331 6,514 - 6,514 Change in fair value of contingent consideration liability (8 ) - (8 ) - (8 ) Amortization of intangibles 1,120 - 1,120 278 H 1,398 Operating (loss) income (1,027 ) 1,042 15 (281 ) (266 ) Other expenses (income) Interest expense 815 - 815 189 A 1,004 Amortization of deferred financing costs 1,125 - 1,125 1 A 1,126 Amortization of debt discounts and conversion options 750 - 750 103 J 853 Change in fair value of derivative liability (60 ) - (60 ) - (60 ) Other income (4 ) - (4 ) - (4 ) (Loss) income before income taxes (3,653 ) 1,042 (2,611 ) (574 ) (3,185 ) Income tax expense 104 - 104 47 K 151 Net (loss) income (3,757 ) 1,042 (2,715 ) (621 ) (3,336 ) Accretion of convertible preferred stock (1,047 ) - (1,047 ) (495 ) B (1,542 ) Net loss applicable to common stockholders $ (4,804 ) $ 1,042 $ (3,762 ) $ (1,116 ) $ (4,878 ) Loss per share applicable to common stockholders (basic and diluted) $ (0.41 ) $ (0.36 ) Weighted average shares outstanding: Basic and diluted 11,692,329 2,000,000 L 13,692,329 JETPAY CORPPORATION Notes to Unaudited Pro Forma Combined Financial Statements Note 1: Organization and basis of pro forma presentation The Company was incorporated in Delaware on November 12, 2010 as a blank check company whose objective was to acquire, through a merger, share exchange, asset acquisition, stock purchase, plan of arrangement, recapitalization, reorganization or other similar business combination, one or more operating businesses. Until December 28, 2012, the Company’s efforts were limited to organizational activities, its initial public offering (the “Offering”) and the search for suitable business acquisition transactions. The Company currently operates in two business segments, the Payment Processing Segment, which is an end-to-end processor of credit and debit card and ACH payment transactions for businesses with a focus on those processing internet transactions and recurring bxxxxxxx and the Payroll Processing Segment, which is a full-service payroll and related payroll tax payment processor. The Company also initiated operati...

Unaudited Pro Forma Combined Statement of Operations. For the nine months ended September 30, 2021 (In U.S. Dollars, except per share data) Historical Zomedica Historical Branford PVT Reclassification Adjustments (Note 3) Transaction Accounting Adjustments (Notes 4 and 5) Pro Forma Total Revenues, net $ 52,331 $ 8,536,541 $ - $ - $ 8,588,782 Cost of revenue 59,433 2,163,195 - - 2,222,628 Gross (loss)/profit (7,102 ) 6,373,256 - - 6,366,154 Expenses Research and development 1,008,083 - - - 1,008,083 Selling, general and administrative 14,593,952 2,995,506 2,155,045 B 912,224 A 20,656,727 Depreciation and amortization - 1,399,698 (1,399,698 )B - - Management fees and expenses, related party - 212,910 (212,910 )B - - Acquisition-related costs - 542,437 (542,437 )B - - (Loss)/income from operations (15,609,137 ) 1,222,705 - (912,224) (15,298,656 ) Interest income (261,556 ) - - - (261,556 ) Interest expense 6,054 1,437,652 - - 1,443,706 Loss on disposal of assets 269,707 - - - 269,707 Gain on extinguishment of debt (533,414 ) (199,935 ) - - (733,349 ) Other (gains)/losses (2,481 ) 27,211 - - 24,730 Foreign exchange loss 5,731 - - - 5,731 ) Loss before income taxes (15,093,178 ) (42,223 ) - (912,224) (16,047,625 ) Income tax expense/(benefit) - (1,036 ) - (1,742,366) B (1,743,402 ) Net (loss)/income $ (15,093,178 ) $ (41,187 ) $ - $ 830,141 $ (14,304,224 ) Weighted average number of common shares – basic and diluted 948,664,410 948,664,410 Loss per share – basic and diluted $ (0.05 ) $ - C $ (0.05 ) Notes to the Unaudited Pro Forma Combined Financial Statements (U.S. dollars, except share and per share data)

Unaudited Pro Forma Combined Statement of Operations. Historical Vystar Corporation Historical SleepHealth, LLC For the Six Months Ended June 30, 2012 For the Six Months Ended June 30, 2012 Pro Forma Adjustments Pro Forma Combined REVENUES, NET $ 144,447 $ 579,080 - $ 723,527 COST OF REVENUES 143,483 415,295 - 558,778 Gross Profit 964 163,785 - 164,749 OPERATING EXPENSES Sales and marketing 214,344 - - 214,344 General and administrative 759,182 210,806 26,344 (I) 1,002,113 5,781 (J) Research and development 23,075 - 23,075 Total Operating Expenses 996,601 210,806 32,125 1,239,532 LOSS FROM OPERATIONS (995,637 ) (47,021 ) (32,125 ) (1,074,783 ) OTHER INCOME (EXPENSE) Interest income 300 - - 300 Other income 5,250 - - 5,250 Interest expense (279,430 ) (8,463 ) (843 )(K) (288,736 ) NET LOSS $ (1,269,517 ) $ (55,484 ) $ (32,968 ) $ (1,357,969 ) Basic and Diluted Loss per Share $ (0.07 ) $ (0.07 ) Basic and Diluted Weighted Average Number of 18,487,791 636,098 (G) 19,123,889 Common Shares Outstanding VYSTAR CORPORATION AND SUBSIDIARIES Unaudited Pro Forma Combined Statement of Operations Historical Vystar Corporation Historical SleepHealth, LLC For the Year Ended December 31, 2011 For the Year Ended December 31, 2011 Pro Forma Adjustments Pro Forma Combined REVENUES, NET $ 347,250 $ 1,270,579 - $ 1,617,829 COST OF REVENUES 226,624 969,991 - 1,196,615 Gross Profit 120,626 300,588 - 421,214 OPERATING EXPENSES Sales and marketing 644,612 13,855 - 658,467 General and administrative 1,886,863 327,226 52,689 (I) 2,283,365 - - 16,587 (J) Research and development 68,426 - - 68,426 Total Operating Expenses 2,599,901 341,081 69,276 3,010,258 LOSS FROM OPERATIONS (2,479,275 ) (40,493 ) (69,276 ) (2,589,044 ) OTHER INCOME (EXPENSE) Interest income 545 - - 545 Other income - 36 - 36 Interest expense (1,122,296 ) (26,045 ) (1,686 )(K) (1,150,027 ) NET LOSS $ (3,601,026 ) $ (66,502 ) $ (70,962 ) $ (3,738,490 ) Basic and Diluted Loss per Share $ (0.23 ) $ (0.23 ) Basic and Diluted Weighted Average Number of 15,595,137 636,098 (G) 16,231,235 Common Shares Outstanding SLEEPHEALTH, LLC Notes to Unaudited Pro Forma Combined Financial Statements

Unaudited Pro Forma Combined Statement of Operations. For the Year Ended December 31, 2021 (In thousands) Xtant (Historical) Surgalign SPV (Historical) Transaction Accounting Adjustments Notes Pro Forma Combined Revenue Orthopedic product sales $ 55,146 $ 17,821 $ — $ 72,967 Other revenue 117 — — 117 Total Revenue 55,263 17,821 — 73,084 Cost of sales 22,773 639 186 5(c) 23,598 Gross Profit 32,490 17,182 (186 ) 49,486 Operating Expenses General and administrative 14,449 406 1,507 5(e) 16,362 Sales and marketing 21,025 8,733 (204 ) 5(d) 29,554 Research and development 870 — — 870 Total Operating Expenses 36,344 9,139 1,303 46,786 (Loss) Income from Operations (3,854 ) 8,043 (1,489 ) 2,700 Other Expense Interest expense (995 ) — (1,282 ) 5(b) (2,277 ) Total Other Expense (995 ) — (1,282 ) (2,277 ) Net (Loss) Income from Operations Before Provision for Income Taxes (4,849 ) 8,043 (2,771 ) 423 Provision for Income Taxes Current and Deferred — — — — Net (Loss) Income $ (4,849 ) $ 8,043 $ (2,771 ) $ 423 Net Loss Per Share: Basic $ (0.06 ) $ 0.00 Dilutive $ (0.06 ) $ 0.00 Shares used in the computation: Basic 85,456,175 85,456,175 Dilutive 85,456,175 86,070,797 See notes to unaudited pro forma condensed combined financial statements.

Related to Unaudited Pro Forma Combined Statement of Operations

Pro Forma Financial Statements Agent shall have received a copy of the Pro Forma Financial Statements which shall be satisfactory in all respects to Lenders;
Financial Statements; Pro Forma Balance Sheet; Projections On or prior to the Initial Borrowing Date, the Administrative Agent shall have received true and correct copies of the historical financial statements, the pro forma financial statements and the Projections referred to in Sections 8.05(a) and (d), which historical financial statements, pro forma financial statements and Projections shall be in form and substance reasonably satisfactory to the Administrative Agent and the Required Lenders.
Pro Forma Statement The Receiver, as soon as practicable after Bank Closing, in accordance with the best information then available, shall provide to the Assuming Institution a pro forma statement reflecting any adjustments of such liabilities and assets as may be necessary. Such pro forma statement shall take into account, to the extent possible, (i) liabilities and assets of a nature similar to those contemplated by Section 2.1 or Section 3.1, respectively, which at Bank Closing were carried in the Failed Bank’s suspense accounts, (ii) accruals as of Bank Closing for all income related to the assets and business of the Failed Bank acquired by the Assuming Institution hereunder, whether or not such accruals were reflected on the Accounting Records of the Failed Bank in the normal course of its operations, and (iii) adjustments to determine the Book Value of any investment in an Acquired Subsidiary and related accounts on the “bank only” (unconsolidated) balance sheet of the Failed Bank based on the equity method of accounting, whether or not the Failed Bank used the equity method of accounting for investments in subsidiaries, except that the resulting amount cannot be less than the Acquired Subsidiary’s recorded equity as of Bank Closing as reflected on the Accounting Records of the Acquired Subsidiary. Any Loan purchased by the Assuming Institution pursuant to Section 3.1 which the Failed Bank charged off during the period beginning the day after the Bid Valuation Date to the date of Bank Closing shall be deemed not to be charged off for the purposes of the pro forma statement, and the purchase price shall be determined pursuant to Section 3.2.
Pro Forma Balance Sheet; Financial Statements The Lenders shall have received (i) the Pro Forma Balance Sheet, (ii) audited consolidated financial statements of the Borrower and its Subsidiaries for the most recently ended fiscal year and (iii) unaudited interim consolidated financial statements of the Borrower and its Subsidiaries for each fiscal quarter ended after the date of the latest applicable financial statements delivered pursuant to clause (i) of this paragraph as to which such financial statements are available.
Unaudited Financial Statements The Acquiring Portfolio shall furnish to the Target Portfolio within ten (10) business days after the Closing Date, an unaudited statement of assets and liabilities and the portfolio of investments and the related statements of operations and changes in net assets as of and for the interim period ending on the Closing Date; such financial statements will represent fairly the financial position and portfolio of investments and the results of its operations as of, and for the period ending on, the dates of such statements in conformity with generally accepted accounting principles applied on a consistent basis during the period involved and the results of its operations and changes in financial position for the periods then ended; and such financial statements shall be certified by the Treasurer of the Acquiring Portfolio as complying with the requirements hereof.
Pro Forma Financial Information The pro forma financial statements included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus include assumptions that provide a reasonable basis for presenting the significant effects directly attributable to the transactions and events described therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma adjustments reflect the proper application of those adjustments to the historical financial statements amounts in the pro forma financial statements included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus. The pro forma financial statements included in the Registration Statement, the Time of Sale Disclosure Package and the Final Prospectus comply as to form in all material respects with the application requirements of Regulation S-X under the Exchange Act.
Pro Forma Calculations Notwithstanding anything to the contrary herein (subject to Section 1.02(j)), the First Lien Net Leverage Ratio, the Total Net Leverage Ratio and the Fixed Charge Coverage Ratio and Consolidated Net Tangible Assets shall be calculated (including for purposes of Sections 2.14 and 2.15) on a Pro Forma Basis with respect to each Specified Transaction occurring during the applicable four quarter period to which such calculation relates, and/or subsequent to the end of such four-quarter period but not later than the date of such calculation; provided that notwithstanding the foregoing, when calculating the First Lien Net Leverage Ratio for purposes of (i) determining the applicable percentage of Excess Cash Flow for purposes of Section 2.05(b), (ii) the Applicable Rate, (iii) the Applicable Commitment Fee and (iv) determining actual compliance (and not Pro Forma Compliance or compliance on a Pro Forma Basis) with the Financial Covenant, any Specified Transaction and any related adjustment contemplated in the definition of Pro Forma Basis (and corresponding provisions of the definition of Consolidated EBITDA) that occurred subsequent to the end of the applicable four quarter period shall not be given Pro Forma Effect. For purposes of determining compliance with any provision of this Agreement which requires Pro Forma Compliance with the Financial Covenant, (x) in the case of any such compliance required after delivery of financial statements for the fiscal quarter ending on or about June 30, 2014, such Pro Forma Compliance shall be determined by reference to the maximum First Lien Net Leverage Ratio permitted for the fiscal quarter most recently then ended for which financial statements have been delivered (or were required to have been delivered) in accordance with Section 6.01, or (y) in the case of any such compliance required prior to the delivery referred to in clause (x) above, such Pro Forma Compliance shall be determined by reference to the maximum First Lien Net Leverage Ratio permitted for the fiscal quarter ending June 30, 2014. With respect to any provision of this Agreement (other than the provisions of Section 6.02(a) or Section 7.08) that requires compliance or Pro Forma Compliance with the Financial Covenant, such compliance or Pro Forma Compliance shall be required regardless of whether the Lux Borrower is otherwise required to comply with such covenant under the terms of Section 7.08 at such time. For purposes of making any computation referred to above:
Pro Forma Balance Sheet The Administrative Agent shall have received the Pro Forma Balance Sheet in form and substance satisfactory to the Administrative Agent and the Required Lenders;
Financial Statements; Fiscal Year The Current Financials were prepared in accordance with GAAP and present fairly, in all material respects, the consolidated financial condition, results of operations, and cash flows of the Companies as of, and for the portion of the fiscal year ending on the date or dates thereof (subject only to normal audit adjustments). All material liabilities of the Companies as of the date or dates of the Current Financials are reflected therein or in the notes thereto. Except for transactions directly related to, or specifically contemplated by, the Loan Documents or disclosed in the Current Financials, no subsequent material adverse changes have occurred in the consolidated financial condition of the Companies from that shown in the Current Financials. The fiscal year of each Company ends on December 31.
Year-End Financial Statements As soon as available but no later than one hundred (100) days after and as of the end of each financial reporting year, a complete copy of Borrower's audit report, which shall include balance sheet, income statement, statement of changes in equity and statement of cash flows for such year, prepared and certified by an independent certified public accountant selected by Borrower and satisfactory to Lender (the "Accountant"). The Accountant's certification shall not be qualified or limited due to a restricted or limited examination by the Accountant of any material portion of Borrower's records or otherwise.

Unaudited Pro Forma Combined Statement of Operations Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Related to Unaudited Pro Forma Combined Statement of Operations